Targeting CD38 with isatuximab and a novel CD38/CD3xCD28 trispecific T-cell engager in older patients with acute myeloid leukemia

被引：2

作者：

Martin-Sanchez, Esperanza ^{[1
]}

Blanco, Laura ^{[1
]}

Kim, Peter S. ^{[2
]}

Bisht, Kamlesh ^{[2
]}

Wang, Hongfang ^{[2
]}

van de Velde, Helgi ^{[2
]}

Jelinek, Tomas ^{[1
,3
,4
]}

Simoes, Catia ^{[1
]}

Prosper, Felipe ^{[1
]}

Miguel, Jesus F. San ^{[1
]}

Alfonso, Ana ^{[1
]}

Bergua, Juan ^{[5
]}

Rodriguez-Veiga, Rebeca ^{[6
]}

Vives, Susana ^{[7
]}

Martinez-Cuadron, David ^{[6
,7
]}

Montesinos, Pau ^{[6
,7
]}

Paiva, Bruno ^{[1
]}

Zabaleta, Aintzane ^{[1
]}

机构：

[1] Clin Univ Navarra, Inst Invest Sanit Navarra, Ctr Invest Med Aplicada, Canc Ctr,CIBER ONC Numbers CB16 12 00369 & CB16 12, Pamplona, Spain

[2] Sanofi R&D, North Amer, Cambridge, MA USA

[3] Univ Ostrava, Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[4] Univ Ostrava, Fac Med, Ostrava, Czech Republic

[5] Hosp San Pedro Alcantara, Caceres, Spain

[6] Hosp Univ La Fe, Valencia, Spain

[7] Hosp Germans Trias I Pujol, Josep Carreras Res Inst, Inst Catala Oncol Badalona, Badalona, Spain

来源：

BLOOD ADVANCES | 2024年 / 8卷 / 15期

关键词：

OPEN-LABEL; DEXAMETHASONE; DARATUMUMAB; LENALIDOMIDE; EXPRESSION; TREAT;

D O I：

10.1182/bloodadvances.2024013212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3875 / 3879

页数：5

共 50 条

[1] A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent for the Treatment of Older Patients with Acute Myeloid Leukemia (AML)
Zabaleta, Aintzane
Martin-Sanchez, Esperanza
Blanco, Laura
Kim, Peter
Bisht, Kamlesh
Wang, Hongfang
Van de Velde, Helgi J.
Jelinek, Tomas
Simoes, Catia
Prosper, Felipe
San-Miguel, Jesus
Martinez-Cuadron, David
Montesinos, Pau
Paiva, Bruno
BLOOD, 2023, 142
[2] A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies
Zabaleta, Aintzane
Blanco, Laura
Kim, Peter S.
Bisht, Kamlesh
Wang, Hongfang
Van de Velde, Helgi
Lasa, Marta
Tamariz-Amador, Luis-Esteban
Rodriguez-Otero, Paula
San-Miguel, Jesus
Paiva, Bruno
Martin-Sanchez, Esperanza
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2262 - 2267
[3] The CD38/CD3xCD28 Trispecific Antibody (SAR442257) Potentially Represents a Novel Therapeutic Strategy for Peripheral T-Cell Lymphomas
Dupuy, Aurelie
Pelletier, Laura
Giustiniani, Jerome
Kim, Peter
Bisht, Kamlesh
Wang, Hongfang
Van de Velde, Helgi J.
Haioun, Corinne
Gaulard, Philippe
Ortonne, Nicolas
BLOOD, 2023, 142
[4] CD28 expression on multiple myeloma cells enhances the cytotoxic activity of CD38/CD28xCD3 trispecific T cell engager
El-Murr, Nizar
Henry, Christophe
Francesconi, Elisa
Attenot, Florence
Virone-Oddos, Angela
Vidard, Laurent
Wu, Lan
Yang, Zhi-Yong
Chiron, Marielle
CANCER RESEARCH, 2020, 80 (16)
[5] Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma
Grab, Anna Luise
Kim, Peter S.
John, Lukas
Bisht, Kamlesh
Wang, Hongfang
Baumann, Anja
Van de Velde, Helgi
Sarkar, Irene
Shome, Debarati
Reichert, Philipp
Manta, Calin
Gryzik, Stefanie
Reijmers, Rogier M.
Weinhold, Niels
Raab, Marc S.
CELLS, 2024, 13 (10)
[6] Targeting CD38 for acute leukemia
Zhong, Xushu
Ma, Hongbing
FRONTIERS IN ONCOLOGY, 2022, 12
[7] A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent in Multiple Myeloma Patients Relapsed and/or Refractory ( RRMM) to Anti-CD38 Monoclonal Antibodies (mAbs)
Zabaleta, Aintzane
Blanco, Laura
Kim, Peter
Bisht, Kamlesh
Wang, Hongfang
Van de Velde, Helgi J.
Lasa, Marta
Tamariz-Amador, Luis-Esteban
Otero, Paula Rodriguez
San Miguel, Jesus
Paiva, Bruno
Martin-Sanchez, Esperanza
BLOOD, 2023, 142
[8] High Ex Vivo Response Rates to CD38/CD28xCD3 Trispecific T Cell Engager in Patients Relapsed after Anti-CD38 and Anti-BCMA Targeted Immunotherapies
Keller, Alana
De Acha, Olivia Perez
Reiman, Lauren T.
Walker, Zachary J.
Jayabalan, David S.
Niesvizky, Ruben
Forsberg, Peter A.
Kim, Peter
Bisht, Kamlesh
Wang, Hongfang
van de Velde, Helgi
Sherbenou, Daniel W.
BLOOD, 2022, 140 : 7097 - 7099
[9] CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Naik, Jyoti
Themeli, Maria
de Jong-Korlaar, Regina
Ruiter, Ruud W. J.
Poddighe, Pino J.
Yuan, Huipin
Bruijn, Joost D. d.
Ossenkoppele, Gert J.
Zweegman, Sonja
Smit, Linda
Mutis, Tuna
Martens, Anton C. M.
de Donk, Niels W. C. J. van
Groen, Richard W. J.
HAEMATOLOGICA, 2019, 104 (03) : E100 - E103
[10] Targetting CD38 in T Cell Acute Lymphoblastic Leukemia
Bride, Karen L.
Vincent, Tiffaney L.
Im, Soo-Yeon
Barrett, David M.
Hermiston, Michelle L.
Horton, Terzah M.
Loh, Mignon L.
Maude, Shannon L.
Grupp, Stephan A.
Wood, Brent
Teachey, David T.
BLOOD, 2017, 130

← 1 2 3 4 5 →